Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease

Neurobiology of Disease

Volumn 34, Issue 1, 2009, Pages 146-154

  Madorsky, Irina ^a   Opalach, Katherine ^a   Waber, Amanda ^a   Verrier, Jonathan D ^a   Solmo, Chelsea ^a   Foster, Thomas ^a   Dunn Jr , William A ^a   Notterpek, Lucia ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Autophagy; Chaperones; Dietary regimen; Myelin; Neuropathy; Schwann cells

Indexed keywords

CHAPERONE; PERIPHERAL MYELIN PROTEIN 22;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DIET RESTRICTION; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY MOTOR SENSORY NEUROPATHY TYPE 1A; INTERMITTENT FASTING; LOCOMOTION; MALE; MOUSE; MYELIN SHEATH; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL;

ANALYSIS OF VARIANCE; ANIMALS; BASEMENT MEMBRANE; CELL PROLIFERATION; CHARCOT-MARIE-TOOTH DISEASE; DISEASE MODELS, ANIMAL; FASTING; LOCOMOTION; MALE; MICE; MICE, MUTANT STRAINS; MYELIN PROTEINS; MYELIN SHEATH; SCHWANN CELLS; SCIATIC NERVE;

EID: 62149126997     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.01.002     Document Type: Article

References (56)

1. Aguayo A.J., Kasarjian J., Skamene E., Kongshavn P., and Bray G.M. Myelination of mouse axons by Schwann cells transplanted from normal and abnormal human nerves. Nature 268 (1977) 753-755
2. Amici S.A., Dunn Jr. W.A., Murphy A.J., Adams N.C., Gale N.W., Valenzuela D.M., Yancopoulos G.D., and Notterpek L. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. J. Neurosci. 26 (2006) 1179-1189
3. Anson R.M., Guo Z., de Cabo R., Iyun T., Rios M., Hagepanos A., Ingram D.K., Lane M.A., and Mattson M.P. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6216-6220
4. Archelos J.J., Roggenbuck K., Schneider-Schaulies J., Toyka K.V., and Hartung H.P. Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis. J. Neurol. Sci. 117 (1993) 197-205
5. Atanasoski S., Scherer S.S., Nave K.A., and Suter U. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A. J. Neurosci. Res. 67 (2002) 443-449
6. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555
7. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., Howitz K.T., Gorospe M., de Cabo R., and Sinclair D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305 (2004) 390-392
8. Colotti C., Cavallini G., Vitale R.L., Donati A., Maltinti M., Del Ry S., Bergamini E., and Giannessi D. Effects of aging and anti-aging caloric restrictions on carbonyl and heat shock protein levels and expression. Biogerontology 6 (2005) 397-406
9. Court F.A., Wrabetz L., and Feltri M.L. Basal lamina: Schwann cells wrap to the rhythm of space-time. Curr. Opin. Neurobiol. 16 (2006) 501-507
10. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835 (1999) 18-26
11. Fortun J., Dunn Jr. W.A., Joy S., Li J., and Notterpek L. Emerging role for autophagy in the removal of aggresomes in Schwann cells. J. Neurosci. 23 (2003) 10672-10680
12. Fortun J., Li J., Go J., Fenstermaker A., Fletcher B.S., and Notterpek L. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J. Neurochem. 92 (2005) 1531-1541
13. Fortun J., Go J.C., Li J., Amici S.A., Dunn Jr. W.A., and Notterpek L. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol. Dis. 22 (2006) 153-164
14. Fortun J., Verrier J.D., Go J.C., Madorsky I., Dunn W.A., and Notterpek L. The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones. Neurobiol. Dis. 25 (2007) 252-265
15. Hanemann C.O., D'Urso D., Gabreels-Festen A.A., and Muller H.W. Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A. Brain 123 Pt 5 (2000) 1001-1006
16. Henry E.W., Cowen J.S., and Sidman R.L. Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination. J. Neuropathol. Exp. Neurol. 42 (1983) 688-706
17. Homma S., Jin X., Wang G., Tu N., Min J., Yanasak N., and Mivechi N.F. Demyelination, astrogliosis, and accumulation of ubiquitinated proteins, hallmarks of CNS disease in hsf1-deficient mice. J. Neurosci. 27 (2007) 7974-7986
18. Huxley C., Passage E., Manson A., Putzu G., Figarella-Branger D., Pellissier J.F., and Fontes M. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5 (1996) 563-569
19. Inoki K., Ouyang H., Li Y., and Guan K.L. Signaling by target of rapamycin proteins in cell growth control. Microbiol. Mol. Biol. Rev. 69 (2005) 79-100
20. Isaacs A.M., Jeans A., Oliver P.L., Vizor L., Brown S.D., Hunter A.J., and Davies K.E. Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy. Mol. Cell. Neurosci. 21 (2002) 114-125
21. Ishihara H., Wenying F., Kouda K., Nakamura H., Kohno H., Nishio N., and Sonoda Y. Effects of dietary restriction on physical performance in mice. J. Physiol. Anthropol. Appl. Hum. Sci. 24 (2005) 209-213
22. Jeronimo A., Jeronimo C.A., Rodrigues Filho O.A., Sanada L.S., and Fazan V.P. Microscopic anatomy of the sural nerve in the postnatal developing rat: a longitudinal and lateral symmetry study. J. Anat. 206 (2005) 93-99
23. Kaya F., Belin S., Bourgeois P., Micaleff J., Blin O., and Fontes M. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul. Disord. 17 (2007) 248-253
24. Khajavi M., Shiga K., Wiszniewski W., He F., Shaw C.A., Yan J., Wensel T.G., Snipes G.J., and Lupski J.R. Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am. J. Hum. Genet. 81 (2007) 438-453
25. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M., Baehrecke E.H., Bahr B.A., Ballabio A., Bamber B.A., Bassham D.C., Bergamini E., Bi X., Biard-Piechaczyk M., Blum J.S., Bredesen D.E., Brodsky J.L., Brumell J.H., Brunk U.T., Bursch W., Camougrand N., Cebollero E., Cecconi F., Chen Y., Chin L.S., Choi A., Chu C.T., Chung J., Clarke P.G., Clark R.S., Clarke S.G., Clave C., Cleveland J.L., Codogno P., Colombo M.I., Coto-Montes A., Cregg J.M., Cuervo A.M., Debnath J., Demarchi F., Dennis P.B., Dennis P.A., Deretic V., Devenish R.J., Di Sano F., Dice J.F., Difiglia M., Dinesh-Kumar S., Distelhorst C.W., Djavaheri-Mergny M., Dorsey F.C., Droge W., Dron M., Dunn Jr. W.A., Duszenko M., Eissa N.T., Elazar Z., Esclatine A., Eskelinen E.L., Fesus L., Finley K.D., Fuentes J.M., Fueyo J., Fujisaki K., Galliot B., Gao F.B., Gewirtz D.A., Gibson S.B., Gohla A., Goldberg A.L., Gonzalez R., Gonzalez-Estevez C., Gorski S., Gottlieb R.A., Haussinger D., He Y.W., Heidenreich K., Hill J.A., Hoyer-Hansen M., Hu X., Huang W.P., Iwasaki A., Jaattela M., Jackson W.T., Jiang X., Jin S., Johansen T., Jung J.U., Kadowaki M., Kang C., Kelekar A., Kessel D.H., Kiel J.A., Kim H.P., Kimchi A., Kinsella T.J., Kiselyov K., Kitamoto K., Knecht E., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4 (2008) 151-175
26. Martin B., Mattson M.P., and Maudsley S. Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res. Rev. 5 (2006) 332-353
27. Martini R., and Schachner M. Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules. Glia 19 (1997) 298-310
28. McIlwain K.L., Merriweather M.Y., Yuva-Paylor L.A., and Paylor R. The use of behavioral test batteries: effects of training history. Physiol. Behav. 73 (2001) 705-717
29. Misko A., Ferguson T., and Notterpek L. Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves. J. Neurochem. 83 (2002) 885-894
30. Mizushima N., Yamamoto A., Matsui M., Yoshimori T., and Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 15 (2004) 1101-1111
31. Morimoto R.I., Kline M.P., Bimston D.N., and Cotto J.J. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem. 32 (1997) 17-29
32. Nishimura T., Yoshikawa H., Fujimura H., Sakoda S., and Yanagihara T. Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A. Acta Neuropathol. 92 (1996) 454-460
33. Notterpek L., and Tolwani R.J. Experimental models of peripheral neuropathies. Lab. Anim. Sci. 49 (1999) 588-599
34. Notterpek L., Shooter E.M., and Snipes G.J. Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J. Neurosci. 17 (1997) 4190-4200
35. Notterpek L., Ryan M.C., Tobler A.R., and Shooter E.M. PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol. Dis. 6 (1999) 450-460
36. Pareek S., Notterpek L., Snipes G.J., Naef R., Sossin W., Laliberte J., Iacampo S., Suter U., Shooter E.M., and Murphy R.A. Neurons promote the translocation of peripheral myelin protein 22 into myelin. J. Neurosci. 17 (1997) 7754-7762
37. Pareyson D., Schenone A., Fabrizi G.M., Santoro L., Padua L., Quattrone A., Vita G., Gemignani F., Visioli F., and Solari A. A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]. Pharmacol. Res. 54 (2006) 436-441
38. Passage E., Norreel J.C., Noack-Fraissignes P., Sanguedolce V., Pizant J., Thirion X., Robaglia-Schlupp A., Pellissier J.F., and Fontes M. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10 (2004) 396-401
39. Patel N.V., Gordon M.N., Connor K.E., Good R.A., Engelman R.W., Mason J., Morgan D.G., Morgan T.E., and Finch C.E. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol. Aging 26 (2005) 995-1000
40. Perkins C.S., Aguayo A.J., and Bray G.M. Behavior of schwann cells from trembler mouse unmyelinated fibers transplanted into myelinated nerves. Exp. Neurol. 71 (1981) 515-526
41. Rangaraju S., Madorsky I., Pileggi J.G., Kamal A., and Notterpek L. Pharmacological induction of the heat shock response improves myelination in a neuropathic model. Neurobiol. Dis. 32 (2008) 105-115
42. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006) 780-786
43. Ryan M.C., Shooter E.M., and Notterpek L. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol. Dis. 10 (2002) 109-118
44. Sanders C.R., Ismail-Beigi F., and McEnery M.W. Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 40 (2001) 9453-9459
45. Sarkar S., Ravikumar B., Floto R.A., and Rubinsztein D.C. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 16 (2008) 46-56
46. Sereda M., Griffiths I., Puhlhofer A., Stewart H., Rossner M.J., Zimmerman F., Magyar J.P., Schneider A., Hund E., Meinck H.M., Suter U., and Nave K.A. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16 (1996) 1049-1060
47. Sereda M.W., Meyer zu Horste G., Suter U., Uzma N., and Nave K.A. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat. Med. 9 (2003) 1533-1537
48. Sharma S., and Kaur G. Intermittent dietary restriction as a practical intervention in aging. Ann. N. Y. Acad. Sci. 1114 (2007) 419-427
49. Soti C., and Csermely P. Aging and molecular chaperones. Exp. Gerontol. 38 (2003) 1037-1040
50. Steinkraus K.A., Smith E.D., Davis C., Carr D., Pendergrass W.R., Sutphin G.L., Kennedy B.K., and Kaeberlein M. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell 7 (2008) 394-404
51. Suter U., and Snipes G.J. Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 18 (1995) 45-75
52. Suter U., Moskow J.J., Welcher A.A., Snipes G.J., Kosaras B., Sidman R.L., Buchberg A.M., and Shooter E.M. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4382-4386
53. Tobler A.R., Liu N., Mueller L., and Shooter E.M. Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 483-488
54. Valentijn L.J., Baas F., Wolterman R.A., Hoogendijk J.E., van den Bosch N.H., Zorn I., Gabreels-Festen A.W., de Visser M., and Bolhuis P.A. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat. Genet. 2 (1992) 288-291
55. Wang Ip C., Kroner A., Fischer S., Berghoff M., Kobsar I., Maurer M., and Martini R. Role of immune cells in animal models for inherited peripheral neuropathies. Neuromol. Med. 8 (2006) 175-190
56. Wohlgemuth S.E., Julian D., Akin D.E., Fried J., Toscano K., Leeuwenburgh C., and Dunn Jr. W.A. Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res. 10 (2007) 281-292